SCHEMBL23219048

SCHEMBL23219048

CCOC(=O)c1coc2c(OCc3cncn3C)cc(Br)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
SYK P43405 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
GAA P10253 1/20 0.34
LMNA P02545 1/20 0.34
MMP2 P08253 1/20 0.34
MMP13 P45452 1/20 0.34
MMP14 P50281 1/20 0.34
MAPT P10636 1/20 0.33
TBXAS1 P24557 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29853169 1.00 RXFP1 (0.36) RXFP1SMN1; SMN2ALDH1A1MAPK1SYK
SCHEMBL23218979 0.81 MAP4K3 (0.32) SYK
SCHEMBL29852777 0.80 TBXAS1 (0.43) SMN1; SMN2ALDH1A1MAPK1SYKPOLB
SCHEMBL23218919 0.80 TBXAS1 (0.43) SMN1; SMN2ALDH1A1MAPK1SYKPOLB
SCHEMBL29852957 0.80 PIM1 (0.52) RXFP1SMN1; SMN2ALDH1A1MAPK1NPSR1
SCHEMBL23218355 0.80 PIM1 (0.52) RXFP1SMN1; SMN2ALDH1A1MAPK1NPSR1
SCHEMBL29591204 0.78 JMJD6 (0.42) RXFP1SMN1; SMN2ALDH1A1MAPK1NPSR1
SCHEMBL23218802 0.78 JMJD6 (0.42) RXFP1SMN1; SMN2ALDH1A1MAPK1NPSR1
SCHEMBL23218491 0.77 MMP9 (0.37) RXFP1SMN1; SMN2ALDH1A1MAPK1NPSR1
SCHEMBL29852830 0.77 MMP9 (0.37) RXFP1SMN1; SMN2ALDH1A1MAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed